Close
Novotech
Jabsco PureFlo 21 Single Use

News

Japan’s Yoshinori Ohsumi wins Nobel for studies of cell ‘self-eating’

Japanese scientist whose experiments explored the machinery by which cells recycle their dilapidated or unwanted contents won the Nobel Prize in physiology or medicine on Monday. Yoshinori Ohsumi, a 71-year-old biologist at the Tokyo Institute of...

Sartorius Stedim Biotech launches two Single-use Sartocon Loop Assemblies with Integrated Polyethersulfone (PESU) Membrane

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry announced its polyethersulfone membrane (PESU) is now integrated into two new, sterile Sartoconยฎ benchtop and production scale filtration assemblies. Using these assemblies guarantees rapid and safe ultrafiltration...

Zuellig Pharma to distribute imdur in eight markets for Topridge Pharma

Zuellig Pharma and TopRidge Pharma Limited have signed a deal that will see Zuellig Pharma distribute Imdur, a mature medicine for the prevention of angina in patients with heart disease, in eight markets across the region. ...

Amgen To Present At The Morgan Stanley Global Healthcare Conference

Amgen will present at the Morgan Stanley Global Healthcare Conference at 10:30 a.m. ET on Wednesday, Sept. 14, 2016, in New York City. Robert A. Bradway, chairman and chief executive officer at Amgen, will present at the conference. ...

Teva to Present at the Wells Fargo 2016 Healthcare Conference

Teva Pharmaceutical Industries Ltd will host a live audio webcast at the Wells Fargo Healthcare Conference. Eyal Desheh will present on Wednesday, September 7, 2016 at 1:10 PM ET. What:ย Teva Presentation at the Wells Fargo 2016...

Teva to Host Generic Medicines Business Overview on September 9, 2016

Teva Pharmaceutical Industries Ltd. announced that it will host a conference call and live webcast along with a slide presentation on Friday, September 9, 2016 at 8:00 a.m. ET to communicate an overview of the future prospects of Teva...

TG Therapeutics Announces TG-1101 for the Treatment of Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder

TG Therapeutics, Inc. announced that the U.S. FDA has granted orphan drug designation for TG-1101 (ublituximab) the Companyโ€™s novel, glycoengineered anti-CD20 monoclonal antibody, for the treatment of patients with neuromyelitis optica (NMO) and neuromyelitis optica spectrum disorder (NMOSD). ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป